Vogipax MP 500mg/7.5mg/0.3mg Tablet
Marketer
Vidakem Lifesciences Pvt Ltd
Salt Composition
Metformin (500mg) + Pioglitazone (7.5mg) + Voglibose (0.3mg)
Overview Vogipax MP 500mg/7.5mg/0.3mg Tablet
Diabetol Trio 500 mg/7.5 mg/0.3 mg tablets are classified as antidiabetic medications. This triple-combination therapy is indicated for managing type 2 diabetes in adults, effectively regulating blood glucose. Diabetol Trio should be administered with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without consulting your doctor can lead to elevated blood sugar, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your healthcare provider. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect, manifested by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential preventative measures. Alcohol consumption should be minimized due to its hypoglycemic effect. Additional potential side effects include nausea, altered taste, diarrhea, abdominal pain, edema, respiratory infections, skin rashes, blurred vision, and fractures. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your doctor before commencing treatment. Pregnant or breastfeeding individuals require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are recommended.
Primary Ingredients of Vogipax MP 500mg/7.5mg/0.3mg Tablet
There is no text provided to rewrite.
Uses of Vogipax MP 500mg/7.5mg/0.3mg Tablet
Managing type 2 diabetes
Major Benefits of Vogipax MP 500mg/7.5mg/0.3mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Vogipax MP 500 mg/7.5 mg/0.3 mg tablets with food.
Common Side effects of Vogipax MP 500mg/7.5mg/0.3mg Tablet:
- Hypoglycemia (low blood glucose level)
- Blurred vision
- Bone fracture
- Diarrhea
- Edema (swelling)
- Nausea
- Respiratory tract infection
- Skin rash
- Stomach pain
- Taste change
- Weight gain
How to use Vogipax MP 500mg/7.5mg/0.3mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Vogipax MP 500 mg/7.5 mg/0.3 mg tablets with a meal.
How Vogipax MP 500mg/7.5mg/0.3mg Tablet works:
Each Vogipax MP tablet (500 mg/7.5 mg/0.3 mg) combines three anti-diabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Vogipax MP 500 mg/7.5 mg/0.3 mg tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
Pregnant individuals should exercise caution with Vogipax MP 500 mg/7.5 mg/0.3 mg Tablets. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the risks and advantages before prescribing this medication. Seek medical advice before taking it.
Breast feedingSAFE IF PRESCRIBED
Lactation and Vogipax MP 500 mg/7.5 mg/0.3 mg tablets appear compatible. Available human data indicate minimal infant risk associated with this medication.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Vogipax MP 500 mg/7.5 mg/0.3 mg tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. Vogipax MP 500 mg/7.5 mg/0.3 mg tablets are contraindicated in those with severe kidney disease. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Vogipax MP 500 mg/7.5 mg/0.3 mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Vogipax MP 500 mg/7.5 mg/0.3 mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Vogipax MP 500mg/7.5mg/0.3mg Tablet :
NA
Facts to Know About Vogipax MP 500mg/7.5mg/0.3mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes medication |
3,018 People bought this recently